X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (27) 27
adult (16) 16
female (16) 16
male (16) 16
schizophrenia (16) 16
psychiatry (14) 14
middle aged (12) 12
life sciences (11) 11
analysis (9) 9
human health and pathology (9) 9
france (8) 8
health care sciences & services (8) 8
psychiatrics and mental health (8) 8
quality of life (8) 8
economics and finance (7) 7
humanities and social sciences (7) 7
psychology (7) 7
santé publique et épidémiologie (7) 7
young adult (7) 7
[ sdv.mhep.psm ] life sciences [q-bio]/human health and pathology/psychiatrics and mental health (6) 6
adolescent (6) 6
aged (6) 6
depression (6) 6
pharmacology & pharmacy (6) 6
public aspects of medicine (6) 6
public health (6) 6
research article (6) 6
schizophrenic psychology (6) 6
studies (6) 6
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (5) 5
[ shs.eco ] humanities and social sciences/economies and finances (5) 5
business (5) 5
care and treatment (5) 5
cost-effectiveness (5) 5
europe (5) 5
guidelines (5) 5
management (5) 5
market access (5) 5
models (5) 5
psychiatry and mental health (5) 5
real-world evidence (5) 5
stigma (5) 5
[ shs.psy ] humanities and social sciences/psychology (4) 4
antipsychotics (4) 4
cohort studies (4) 4
cost-benefit analysis (4) 4
disease (4) 4
disorders (4) 4
economic aspects (4) 4
economics (4) 4
efficacy (4) 4
health aspects (4) 4
health policy & services (4) 4
internal medicine (4) 4
ischemic-heart-disease (4) 4
literature reviews (4) 4
medicine (4) 4
medicine, general & internal (4) 4
mental disorders (4) 4
meta-analysis (4) 4
models, theoretical (4) 4
mortality (4) 4
nalmefene (4) 4
naltrexone - analogs & derivatives (4) 4
original (4) 4
patients (4) 4
pharmaceutical industry (4) 4
population survey (4) 4
quality (4) 4
quality-of-life (4) 4
quantitative finance (4) 4
review (4) 4
social distance (4) 4
systematic review (4) 4
validation (4) 4
[sdv.mhep.psm]life sciences [q-bio]/human health and pathology/psychiatrics and mental health (3) 3
anticoagulation (3) 3
attitudes (3) 3
burden (3) 3
clinical trials (3) 3
computer simulation (3) 3
cost analysis (3) 3
cross-cultural comparison (3) 3
diagnosis (3) 3
drugs (3) 3
economic model (3) 3
funding (3) 3
germany (3) 3
health (3) 3
health care economics and organizations (3) 3
health economics (3) 3
health policy (3) 3
medicine, research & experimental (3) 3
metaanalysis (3) 3
pharmacoeconomics (3) 3
prevalence (3) 3
psychiatric services (3) 3
psychopathology (3) 3
public health, environmental and occupational health (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2018, Volume 6, Issue 1, pp. 1508272 - 10
Background: Economic models are broadly used in the economic evaluation of antipsychotics in schizophrenia. Our objective was to summarize the structure of... 
Schizophrenia | antipsychotics | economic model | pharmacoeconomics | pharmacotherapy | model structure | Psychotropic drugs | Economic models | Systematic review | Drug therapy | Pharmacoeconomics
Journal Article
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 11/2019, Volume 35, Issue 11, pp. 1867 - 1872
Objective: The aim of this study was to investigate the impact of methodological choices in a meta-analysis of real-world evidence (RWE) comparing three... 
meta-analysis | real-world evidence | Non-valvular atrial fibrillation | vitamin K antagonist | anticoagulation | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | WARFARIN | RIVAROXABAN
Journal Article
Value in Health, ISSN 1098-3015, 2015, Volume 18, Issue 7, pp. A521 - A521
The Social Security Funding Law for 2012 introduced the Economic and Public Health Assessment Committee (Commission Evaluation Economique et de Santé Publique,... 
Internal Medicine | Chemical industry | Health economics | Medical technology | Funding | Health care policy | Committees | Public health
Journal Article
Cardiovascular Research, ISSN 0008-6363, 11/2019
Abstract Aims In the COMPASS trial, rivaroxaban 2.5 mg twice daily (bid) plus acetylsalicylic acid (ASA) 100 mg once daily (od) performed better than ASA 100... 
Journal Article
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2019, Volume 7, Issue 1, p. 1648973
Background and Objectives: Utility elicitation studies for schizophrenia generate different utility values for the same health states. We reviewed utility... 
antipsychotics | economic model | Utility | schizophrenia | pharmacoeconomics | utility
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2016, Volume 4, Issue 1, pp. 30725 - 9
There is controversy as to whether use of statistical clustering methods to identify common disease patterns in schizophrenia identifies patterns generalizable... 
USA | outcome assessment | disease states | schizophrenia | Europe | validation | Cluster analysis | Schizophrenia | Comparative studies | Principal components analysis | Psychopathology | Psychiatry | Methods
Journal Article
Journal of Studies on Alcohol and Drugs, ISSN 1937-1888, 11/2017, Volume 78, Issue 6, p. 867
Objective: A microsimulation model was adapted to evaluate the cost-effectiveness of nalmefene combined with psychosocial support (NMF + PS) versus... 
Alcohol related | Medical treatment | Clinical trials | Clinical research | Nalmefene | Clinical outcomes | Alcohol use | Social psychology | Sensitivity | Psychosocial support | Robustness | Cost analysis | Psychosocial factors | Quality adjusted life years
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2014, Volume 2, Issue 1, p. 22814
Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug... 
repositioning | market access | repurposing | reimbursement | reformulation | price | Pharmaceutical industry | Research & development--R&D | Funding | Drug dosages | Intellectual property | Price levels
Journal Article
Applied Health Economics and Health Policy, ISSN 1175-5652, 8/2016, Volume 14, Issue 4, pp. 493 - 505
Alcohol dependence causes considerable harm to patients. Treatment with nalmefene, aiming to reduce consumption rather than maintain complete abstinence, has... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | METAANALYSIS | LINEAR MIXED MODELS | PERSPECTIVE | DRINKING | ISCHEMIC-HEART-DISEASE | ALL-CAUSE MORTALITY | INJURY MORTALITY | LIVER-CIRRHOSIS | RISK-FACTOR | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | ECONOMICS | BURDEN | Naltrexone - analogs & derivatives | Naltrexone - therapeutic use | Multicenter Studies as Topic - statistics & numerical data | Clinical Trials as Topic - statistics & numerical data | Europe | Humans | Alcohol Drinking - drug therapy | Alcohol Drinking - psychology | Social Support | Public Health - methods | Alcohol Drinking - adverse effects | Outcome and Process Assessment (Health Care) - statistics & numerical data | Narcotic Antagonists - therapeutic use | Computer Simulation | Harm Reduction - drug effects | Public Health - statistics & numerical data | Alcoholism - complications | Alcoholism - drug therapy | Alcoholism - psychology | Alcoholic beverages | Management | Patients | Health aspects | Public health | Risk factors | Confidence intervals | Disease | Womens health | Mortality | Technical communication | Clinical trials | Liver cirrhosis | Injuries | Alcohol use | Life Sciences | Human health and pathology | Economics and Finance | Psychology | Santé publique et épidémiologie | Humanities and Social Sciences | Psychiatrics and mental health
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 12/2018, Volume 34, Issue 12, pp. 2125 - 2130
Objectives: To identify existing guidelines, key recommendations, and existing limitations regarding the evaluation and use of real-world evidence (RWE) in... 
Systematic review | Bias | Real-world evidence | Meta-analysis | Guidelines | MEDICINE, RESEARCH & EXPERIMENTAL | RANDOMIZED CONTROLLED-TRIALS | BIAS ADJUSTMENT | MEDICINE, GENERAL & INTERNAL
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, p. S693
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S693 - S693
Journal Article
Quality of Life Research, ISSN 0962-9343, 04/2016, Volume 25, Issue 4, pp. 925 - 934
The clinical symptoms of schizophrenia are associated with serious ă social, quality of life and functioning alterations. Typically, data on ă health utilities... 
Life Sciences | Human health and pathology | Economics and Finance | Psychology | Santé publique et épidémiologie | Humanities and Social Sciences | Psychiatrics and mental health
Journal Article
Journal of Market Access & Health Policy, ISSN 2001-6689, 01/2014, Volume 2, Issue 1, p. 22813
Repurposing has become a mainstream strategy in drug development, but it faces multiple challenges, amongst them the increasing and ever changing regulatory... 
repositioning | market access | repurposing | regulation | reformulation | regulatory | Drugs | Patents | Weight control | Intellectual property | Trademarks | FDA approval | Pharmaceutical industry | Alzheimers disease | Data bases
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.